These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9322588)

  • 1. Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features.
    Wilson CS; Traweek ST; Slovak ML; Niland JC; Forman SJ; Brynes RK
    Am J Clin Pathol; 1997 Oct; 108(4):369-77. PubMed ID: 9322588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.
    Traweek ST; Slovak ML; Nademanee AP; Brynes RK; Niland JC; Forman SJ
    Blood; 1994 Aug; 84(3):957-63. PubMed ID: 8043877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma.
    Brynes RK; Wilson CS; Kim AB; McCourty A
    Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy.
    Miller JS; Arthur DC; Litz CE; Neglia JP; Miller WJ; Weisdorf DJ
    Blood; 1994 Jun; 83(12):3780-6. PubMed ID: 8204897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Friedberg JW; Neuberg D; Stone RM; Alyea E; Jallow H; LaCasce A; Mauch PM; Gribben JG; Ritz J; Nadler LM; Soiffer RJ; Freedman AS
    J Clin Oncol; 1999 Oct; 17(10):3128-35. PubMed ID: 10506609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
    Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic and cytogenetic analyses of 99 cases of de novo myelodysplastic syndromes.
    D'Emilio A; Montaldi A; Stella M; Celli P; Guercini N; Tremul L; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):61-5. PubMed ID: 8039762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS.
    Amigo ML; del Cañizo MC; Rios A; Garcia MA; Caballero MD; Martin A; Bermejo N; Vilches P; San Miguel JF
    Bone Marrow Transplant; 1999 May; 23(10):997-1002. PubMed ID: 10373064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome with bone marrow eosinophilia: clinical and cytogenetic features.
    Matsushima T; Murakami H; Tsuchiya J
    Leuk Lymphoma; 1994 Nov; 15(5-6):491-7. PubMed ID: 7874007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
    Laughlin MJ; McGaughey DS; Crews JR; Chao NJ; Rizzieri D; Ross M; Gockerman J; Cirrincione C; Berry D; Mills L; Defusco P; LeGrand S; Peters WP; Vredenburgh JJ
    J Clin Oncol; 1998 Mar; 16(3):1008-12. PubMed ID: 9508184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndromes: preleukemic syndromes].
    Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-related myelodysplastic syndrome of recipient origin after allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
    Au WY; Lie AK; Ma SK; Leung YH; Siu LL; Kwong YL
    Br J Haematol; 2001 Feb; 112(2):424-6. PubMed ID: 11167842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal studies after bone marrow transplantation for leukaemia in children.
    van den Berg H; Beverstock G; Westerhof JP; Vossen JM
    Bone Marrow Transplant; 1991 May; 7(5):335-42. PubMed ID: 2070142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma.
    Legare RD; Gribben JG; Maragh M; Hermanowski-Vosatka A; Roach S; Tantravahi R; Nadler LM; Gilliland DG
    Am J Hematol; 1997 Sep; 56(1):45-51. PubMed ID: 9298868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation.
    Nevill TJ; Fung HC; Shepherd JD; Horsman DE; Nantel SH; Klingemann HG; Forrest DL; Toze CL; Sutherland HJ; Hogge DE; Naiman SC; Le A; Brockington DA; Barnett MJ
    Blood; 1998 Sep; 92(6):1910-7. PubMed ID: 9731047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.